109 results on '"Falcioni S"'
Search Results
2. Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 y with Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study
3. Modified BEAM as conditioning regimen for lymphoma patients undergoing autologous hematopoietic stem cell transplantation
4. Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey)
5. Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey)
6. GITMO Registry Study on Allogeneic Transplantation in Patients Aged ≥60 Years from 2000 to 2017: Improvements and Criticisms
7. Antiemetic prophylaxis in patients undergoing hematopoietic stem cell transplantation: a multicenter survey of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) transplant programs
8. Reduced incidence of GVHD without increase in relapse with low-dose rabbit ATG in the preparative regimen for unrelated bone marrow transplants in CML
9. The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo Osseo
10. Use of anti-BDCA-2 antibody for detection of dendritic cells type-2 (DC2) in allogeneic hematopoietic stem cell transplantation
11. Different immune reconstitution in multiple myeloma, chronic myeloid leukemia and acute myeloid leukemia patients after allogeneic transplantation of peripheral blood stem cells
12. A novel high-dose therapy regimen with Bendamustine, Etoposide, Cytarabine and Melphalan (BeEAM) followed by autologous stem cell rescue is safe and highly effective for resistant/relapsed lymphoma patients: a phase I-II study on 44 patients: P854
13. Successful treatment of severe hemorrhagic cystitis with selective vesical artery embolization
14. Reduced-intensity conditioning regimen for advanced haematological malignancies: a single-centre retrospective study
15. Low incidence of relapse in patients submitted to allogeneic stem cell transplantation for myelodysplastic syndromes or secondary acute myeloid leukaemia. A single-centre retrospective study
16. Low-dose rabbit ATG prevents GvHD in sibling allogeneic peripheral blood stem cell transplantation for chronic myeloid leukaemia
17. Clinical and prognostic evaluation of cGvHD after sibling allogeneic peripheral blood stem cell transplantation. A large, single centre analysis
18. Calibration of the Simulation model of the HERB building in Bologna in its Present State
19. Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey
20. Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia after Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey
21. ‘Real-life’ report on the management of chronic GvHD in the Gruppo Italiano Trapianto Midollo Osseo (GITMO)
22. Modified BEAM as conditioning regimen for lymphoma patients undergoing autologous hematopoietic stem cell transplantation
23. XRCC1 399GG GENOTYPE PREDICTS SIGNIFICANTLY LONGER OVERALL SURVIVAL AND LONG LASTING CR IN RESISTANT LYMPHOMA TREATED WITH BENDA-BEAM AND ASCT
24. Final analysis of the multicenter phase II 'Bologna 2002' study incorporating thalidomide-dexamethasone (thal-dex) into up-front double autologous stem-cell transplantation (ASCT) for multiple myeloma
25. Test di risposta termica di sonde geotermiche ad U con valutazione numerica
26. INCORPORATION OF THALIDOMIDE INTO UP-FRONT DOUBLE AUTOLOGOUS TRANSPLANTATION FOR MULTIPLE MYELOMA: PROGNOSTIC RELEVANCE OF BASELINE CYTOGENETIC ABNORMALITIES
27. BENEFITS OFFERED BY INCORPORATION OF THALIDOMIDE INTO UP-FRONT DOUBLE AUTOLOGOUS TRANSPLANTATION FOR MULTIPLE MYELOMA
28. Myeloablative allogeneic stem cell transplantation for hematological malignancies in elderly patients: is it safe and efficacious?
29. The relevance of disease phase at transplant before allogneic stem cell transplantation for AML: single center experience
30. Low incidence of relapse in patients submitted to allogeneic SCT for myelodysplastic syndromes or secondary acute myeloid leukemia. A single-centre retrospective study
31. Role of the phase of the disease at transplant in acute myeloid leukemia patients: experience of Bologna
32. Allogeneic Stem Cell Transplantation (SCT) for myelodysplastic synromes (MDS) and secondary acute myeloid leukemia. Retrospective study of 32 patients from a single institution
33. High TRM in allogeneic bone marrow transplantation (BMT) from VUD in primary refractory/relapsed acute leukaemia patients
34. Monocyte chemoattractant protein-1 is strongly expressed during the process of wearing of metal on metal hip prosthesis
35. A Novel High Dose Chemotherapy Strategy With Bendamustine in Adjunct to Etoposide, Cytarabine and Melphalan (BeEAM) Followed by Autologous Stem Cell Rescue Is Safe and Highly Effective for the Treatment of Resistant/Relapsed Lymphoma Patients: A Phase I-II Study on 44 Patients
36. Swelling of a granular hydrogel medium under confinement: individual and collective dynamic
37. XRCC1 399GG GENOTYPE PREDICTS LONG LASTING CR AND SIGNIFICANTLY LONGER OVERALL SURVIVAL IN RESISTANT LYMPHOMA TREATED WITH BENDA-BEAM AND ASCT
38. ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS OLDER THAN 60 YEARS: A REGISTRY STUDY OF THE TRANSPLANT ACTIVITY FROM 2000 TO 2017 ON BEHALF OF THE GRUPPO ITALIANO TRAPIANTO DI MIDOLLO OSSEO (GITMO)
39. Challenges for bone mineral density calibration on micro-CT
40. A NOVEL HIGH DOSE CHEMOTHERAPY STRATEGY WITH BENDAMUSTINE IN ADJUNCT TO ETOPOSIDE, ARACYTIN AND MELPHALAN (BEEAM) FOLLOWED BY AUTOLOGOUS STEM CELL RESCUE IS SAFE AND HIGHLY EFFECTIVE FOR THE TREATMENT OF RESISTANT/RELAPSED LYMPHOMA PATIENTS: A PHASE I-II STUDY ON 33 PATIENTS
41. Low-dose rabbit ATG prevents GvHD in sibling allogeneic peripheral blood stem cell transplantation for chronic myeloid leukaemia
42. Delayed non-infectious lung disease in allogeneic bone marrow transplant recipients
43. Allogeneic peripheral blood stem cell transplantation for hematological malignancies: an analysis of 119 patients
44. Clinical and prognostic evaluation of cGvHD after sibling allogeneic peripheral blood stem cell transplantation. A large, single centre analysis
45. 98 Infusion of high numbers of G-CSF mobilized blood dendritic cells type 2 (DC-2) is associated with an increased rate of chronic GVHD in allogeneic PBSC transplantation
46. GITMO Registry Study on Allogeneic Transplantation in Patients Aged ≥60 Years from 2000 to 2017: Improvements and Criticisms
47. Thermal conductivity measurement of insulating innovative building materials by hot plate and heat flow meter devices: A Round Robin Test
48. Acute graft-versus-host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation
49. Indagine sperimentale sulle prestazioni in opera di materiali resilienti anticalpestio
50. The Models of Capillary Tube Expansion Devices and the Transients of the Refrigeration Equipments
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.